How do patients with heart failure with preserved ejection fraction die? (Q38101027)

28 August 2017

How do patients with heart failure with preserved ejection fraction die? (English)

1 reference

Heart failure with preserved ejection fraction

28 August 2017

0 references

1 reference

1 reference

2

Carolyn S P Lam

1 reference

28 August 2017

Michelle M Y Chan

1

1 reference

28 August 2017

21 April 2013

1 reference

European Journal of Heart Failure

28 August 2017

1 reference

28 August 2017

15

1 reference

28 August 2017

6

1 reference

28 August 2017

604-613

1 reference

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

28 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Trends in prevalence and outcome of heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Heart failure with preserved systolic function. A different natural history?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Congestive heart failure in the elderly: comparison between reduced ejection fraction and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Irbesartan in patients with heart failure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Outcome of heart failure with preserved ejection fraction in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Systolic and diastolic heart failure in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: Results from a cohort of 2,258 hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Can brain natriuretic peptide be used to guide the management of patients with heart failure and a preserved ejection fraction? The wrong way to identify new treatments for a nonexistent disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Mode of death in chronic heart failure. A request and proposition for more accurate classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Death in heart failure: a community perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Sudden cardiac death in heart failure patients with preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Mode of death in patients with heart failure and reduced vs. preserved ejection fraction: report from the registry of hospitalized heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Hospitalized heart failure: rates and long-term mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Comparison of morbidity in women versus men with heart failure and preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Sex Differences in Clinical Characteristics and Prognosis in a Broad Spectrum of Patients With Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Body mass index and mortality in heart failure: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Diastolic heart failure in the elderly: in-hospital and long-term outcome after the first episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Prognosis and Determinants of Survival in Patients Newly Hospitalized for Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

Obesity and survival in patients with heart failure and preserved systolic function: A U-shaped relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT062

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFT062

1 reference

28 August 2017

1 reference

PubMed ID

23610137